- Home
- TRUG vs PPBT Comparison
TRUG vs PPBT Comparison
Compare TRUG & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUG
- PPBT
- Stock Information
- Founded
- TRUG 1983
- PPBT 2010
- Country
- TRUG United States
- PPBT Israel
- Employees
- TRUG N/A
- PPBT N/A
- Industry
- TRUG
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- TRUG
- PPBT Health Care
- Exchange
- TRUG NYSE
- PPBT Nasdaq
- Market Cap
- TRUG 7.7M
- PPBT 7.1M
- IPO Year
- TRUG N/A
- PPBT N/A
- Fundamental
- Price
- TRUG $0.28
- PPBT $2.73
- Analyst Decision
- TRUG Strong Buy
- PPBT Strong Buy
- Analyst Count
- TRUG 1
- PPBT 1
- Target Price
- TRUG $2.00
- PPBT $33.00
- AVG Volume (30 Days)
- TRUG 1.3M
- PPBT 16.2K
- Earning Date
- TRUG 04-15-2025
- PPBT 05-20-2025
- Dividend Yield
- TRUG N/A
- PPBT N/A
- EPS Growth
- TRUG N/A
- PPBT N/A
- EPS
- TRUG N/A
- PPBT N/A
- Revenue
- TRUG $21,858,864.00
- PPBT N/A
- Revenue This Year
- TRUG $24.05
- PPBT N/A
- Revenue Next Year
- TRUG $31.65
- PPBT N/A
- P/E Ratio
- TRUG N/A
- PPBT N/A
- Revenue Growth
- TRUG 6.19
- PPBT N/A
- 52 Week Low
- TRUG $0.22
- PPBT $2.00
- 52 Week High
- TRUG $1.75
- PPBT $20.60
- Technical
- Relative Strength Index (RSI)
- TRUG 43.17
- PPBT 51.95
- Support Level
- TRUG $0.23
- PPBT $2.67
- Resistance Level
- TRUG $0.39
- PPBT $2.75
- Average True Range (ATR)
- TRUG 0.06
- PPBT 0.21
- MACD
- TRUG 0.00
- PPBT 0.04
- Stochastic Oscillator
- TRUG 33.83
- PPBT 67.19
About TRUG TRUGOLF HOLDINGS INC
TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games ("Links"), innovative hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.